Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab
Clinical trial NCT07151508 · COMPLETED
Trial details
- NCT number
- NCT07151508
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-19
- Primary completion
- 2024-12-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.